Tema Cardiovascular and Metabolics ETF (HRTS) Institutional Ownership $28.94 +0.10 (+0.35%) As of 10:30 AM Eastern Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$3.29MNumber ofInstitutional Sellers(last 12 months)0 Get HRTS Insider Trade Alerts Want to know when executives and insiders are buying or selling Tema Cardiovascular and Metabolics ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HRTS Institutional Buying and Selling by Quarter Tema Cardiovascular and Metabolics ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025 Flow Traders U.S. LLC56,441$1.66M0.1%N/A2.971% 5/7/2025 Sterling Investment Advisors Ltd.178,603$5.24M1.3%+6.5%9.400% 2/4/2025 Sterling Investment Advisors Ltd.167,703$4.84M1.2%+5.7%7.291% 10/24/2024 Sterling Investment Advisors Ltd.158,695$5.33M1.4%+3.7%6.399% 8/5/2024 Sterling Investment Advisors Ltd.153,090$5.10M1.4%+20.6%6.027% (Data available from 1/1/2016 forward) HRTS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HRTS shares? During the previous two years, the following institutional investors and hedge funds held shares of Tema Cardiovascular and Metabolics ETF shares: Sterling Investment Advisors Ltd. ($5.24M), Flow Traders U.S. LLC ($1.66M).Learn more on HRTS's institutional investors. Which institutional investors have been buying Tema Cardiovascular and Metabolics ETF stock? The following institutional investors have purchased Tema Cardiovascular and Metabolics ETF stock in the last 24 months: Flow Traders U.S. LLC ($56.44K), and Sterling Investment Advisors Ltd. ($51.64K). How much institutional buying is happening at Tema Cardiovascular and Metabolics ETF? Institutional investors have bought a total of 108,084 shares in the last 24 months. This purchase volume represents approximately $3.29M in transactions. Related Companies FMED Major Shareholders TARK Major Shareholders FDFF Major Shareholders BLCN Major Shareholders SPRX Major Shareholders AGNG Major Shareholders SARK Major Shareholders XAIX Major Shareholders FDNI Major Shareholders DEMZ Major Shareholders This page (NASDAQ:HRTS) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.